New oral sedative studied in children to improve pre-surgery dosing
NCT ID NCT03639428
First seen Jun 17, 2026
Summary
This study looked at how a new oral form of midazolam (ADV6209) is processed in the body of children aged 6 months to 17 years before surgery. 37 children received a single dose based on their weight. Researchers measured drug levels in the blood to understand how age affects clearance and to support future dosing recommendations. The goal was not to test effectiveness but to gather pharmacokinetic data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIDAZOLAM are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
midazolam (oral solution ADV6209)
What this could lead to
If successful, this could lead to better dosing guidelines for midazolam in children, making pre-surgery sedation safer and more predictable.
What could go wrong
This is a small, early-phase study (37 children) focused on drug levels, not on proving effectiveness or safety. Results may not apply to all children or clinical settings.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.